Microplastic (MP) pollution is a potential threat to marine organisms. In vitro toxicity of MPs and other pollutants, such as pharmaceutically active compounds (PhACs) and brominated flame retardants (BFRs), has been understudied. This study aimed to investigate the effects of polystyrene microplastics (PS-MPs) with different particle sizes on two biomarkers: ethoxyresorufin-O-deethylase (EROD) and glutathione S-transferase (GST) in tilapia liver homogenates. The study also examined the combined effects of PS-MPs with various environmental contaminants, including three metal ions (Cu2+, Zn2+, Pb2+), three BFRs, and six PhACs. PS-MPs alone had no remarkable effects on the two biomarkers at the selected concentrations. However, PS-MPs combined with other pollutants significantly affected the two biomarkers in most situations. For EROD activity, PS + metal ions (except Zn2+ at 1000 μg/L), PS + BFRs (except decabromodiphenyl oxide (BDE-209)) or PS+ trimethoprim (TMP) significantly inhibited activity values, whereas PS+ 4-acetaminophen (AMP) induced EROD activity. For GST, PS together with most tested pollutants (except PS+ ibuprofen (IBF)) greatly decreased the activities. Accordingly, future research should focus on combined toxicity of mixtures to set more reasonable environmental safety evaluation standards.

Veterinary medications are constantly being used for the diagnosis, treatment, and prevention of diseases in livestock. However, untreated veterinary drug active compounds are interminably discharged into numerous water bodies and terrestrial ecosystems, during production procedures, improper disposal of empty containers, unused medication or animal feed, and treatment procedures. This exhaustive review describes the different pathways through which veterinary medications enter the environment, discussing the role of agricultural practices and improper disposal methods. The detrimental effects of veterinary drug compounds on aquatic and terrestrial ecosystems are elaborated with examples of specific veterinary drugs and their known impacts. This review also aims to detail the mechanisms by which microbes degrade veterinary drug compounds as well as highlighting successful case studies and recent advancements in microbe-based bioremediation. It also elaborates on microbial electrochemical technologies as an eco-friendly solution for removing pharmaceutical pollutants from wastewater. Lastly, we have summarized potential innovations and challenges in implementing bioremediation on a large scale under the section prospects and advancements in this field.

Discharging pharmaceutically active drugs into water and wastewater has become a significant environmental threat. Traditional methods are unable to effectively remove these compounds from wastewater, so it is necessary to search for more effective methods. This study investigates the potential of MIL-101(Cr)-NH2 as a preferable and more effective adsorbent for the adsorption and removal of pharmaceutically active compounds from aqueous solutions. By utilizing its large porosity, high specific surface area, and high stability, the structural and transport properties of three pharmaceutically active compounds naproxen (NAP), diclofenac (DIC) and sulfamethoxazole (SMX)) studied using molecular dynamics simulation. The results indicate that the MIL-101(Cr)-NH2 adsorbent is suitable for removing drug molecules from aqueous solutions, with maximum adsorption capacities of 697.75 mg/g for naproxen, 704.99 mg/g for diclofenac, and 725.51 mg/g for sulfamethoxazole.

Pharmaceutically active compounds are an important category of emerging pollutants, and their biological transformation processes in the environment are crucial for understanding and evaluating the migration, transformation, and environmental fate of emerging pollutants. The cytochrome P450 105 enzyme family has been proven to play an important role in the degradation of exogenous environmental pollutants. However, its thermostability and catalytic activity still need to be improved to better adapt to complex environmental conditions. This work elucidates the key mechanisms and important residues of the degradation reaction through multiple computational strategies, establishes a mutation library, and obtains 21 single-point mutation designs. Experimental verification showed that 16 single mutants had enhanced thermostability, with the R89F and L197Y mutants showing the highest increases in thermostability at 135 and 119% relative to the wild-type enzyme, respectively. Additionally, as a result of the higher specific activity of D390Q, it was selected for combination mutagenesis, ultimately resulting in three combination mutants (R89F/L197Y, R89F/D390Q, and R89F/L197Y/D390Q) with enhanced thermostability and catalytic activity. This study provides a modification approach for constructing efficient enzyme variants through semirational design and can contribute to the development of control technologies for emerging pollutants.

This study assesses the risk due to Emerging Contaminants (ECs), present in Indian rivers - Ganga (650 million inhabitants), Yamuna (57 million inhabitants), and Musi (7,500,000 inhabitants), 13 ECs in total, have been used for risk assessment studies. Their concentrations (e.g., Fluconazole: 236950 μg/l, Ciprofloxacin: 31000 μg/l, Caffeine: 21.57 μg/l, etc.) were higher than the threshold concentrations for safe consumption (e.g. Fluconazole allowable level is 3.8 μg/l, and Ciprofloxacin allowable level is 0.51 μg/l). Three different pathways of emerging contaminants (ECs) transfer (oral water ingestion, oral fish ingestion, and dermal water contact) have been considered and the study is carried out in 2 ways: (i) deterministic and (ii) probabilistic approaches (using Monte Carlo iterative methods with 10000 simulations) with the aid of a software - Risk (version 7.5). The risk value, quantified by Hazard Quotient (HQ) is higher than the allowable limit of 1 for several compounds in the three rivers like Fluconazole (HQ = 18276.713), Ciprofloxacin (HQ = 278.675), Voriconazole (HQ = 14.578), Cetirizine (HQ = 1006.917), Moxifloxacin (HQ = 8.076), Caffeine (HQ = 55.150), and Ibuprofen (HQ = 9.503). Results show that Fluconazole and Caffeine pose the maximum risk in the rivers via the \"oral pathway\" that allows maximum transfer of the ECs present in the river (93% and 82% contribution to total risk). The risk values vary from nearly 25 times to 19000 times the United States Environmental Protection Agency (USEPA) threshold limit of 1 (e.g., Caffeine Infant Risk = 25.990 and Fluconazole Adult Risk = 18276.713). The most susceptible age group, from this study, is \"Adults\" (19-70 years old), who stand the chance of experiencing the adverse health hazards associated with prolonged over-exposure to the ECs present in the river waters. Musi has the maximum concentration of pollutants and requires immediate remediation measures. Further, both methods indicate that nearly 60-70% of the population in all the three study areas are at risk of developing health hazards associated with over-exposure to ECs regularly, making the areas inhabitable.

The existence of pharmaceutically active compounds (PhACs) in the water is a major concern for environmentalists due to their deleterious effects on living organisms even at minuscule concentrations. This review focuses on PhACs such as analgesics and anti-inflammatory compounds, which are massively excreted in urine and account for the majority of pharmaceutical pollution. Furthermore, other PhACs such as anti-epileptics, beta-blockers and antibiotics are discussed because they also contribute significantly to pharmaceutical pollution in the aquatic environment. This review is divided into two parts. In the first part, different classes of PhACs and their fate in the wastewater environment are presented. In the second part, recent advances in the removal of PhACs by conventional wastewater treatment plants, including membrane bioreactors (MBRs), activated carbon adsorption and bench-scale studies concerning a broad range of advanced oxidation processes (AOPs) that render practical and appropriate strategies for the complete mineralization and degradation of pharmaceutical drugs, are reviewed. This review indicates that drugs like diclofenac, naproxen, paracetamol and aspirin are removed efficiently by conventional systems. Activated carbon adsorption is suitable for the removal of diclofenac and carbamazepine, whereas AOPs are leading water treatment strategies for the effective removal of reviewed PhACs.

The ability of fungal species to produce a wide range of enzymes and metabolites, which act synergistically, makes them valuable tools in bioremediation, especially in the removal of pharmaceutically active compounds (PhACs) from contaminated environments. PhACs are compounds that have been specifically designed to treat or alter animal physiological conditions and they include antibiotics, analgesics, hormones, and steroids. Their detrimental effects on all life forms have become a source of public outcry due their persistent nature and their uncontrolled discharge into various wastewater effluents, hospital effluents, and surface waters. Studies have however shown that fungi have the necessary metabolic machinery to degrade PhACs in complex environments, such as soil and water, in addition they can be utilized in bioreactor systems to remove PhACs. In this regard, this review highlights fungal species with immense potential in the biodegradation of PhACs, their enzymatic arsenal as well as the probable mechanism of biodegradation. The challenges encumbering the real-time application of this promising bioremediative approach are also highlighted, as well as the areas of improvement and future perspective. In all, this paper points researchers to the fact that fungal bioremediation is a promising strategy for addressing the growing issue of pharmaceutical contamination in the environment and can help to mitigate the negative impacts on ecosystems and human health.

In the present study, 60 emerging contaminants (ECs) were detected from 88 target compounds in the district of Wujin, which is the northwest area of Tai Lake Basin, China. Among them, CF (caffeine), a type of PhAC (pharmaceutically active compound), was detected as the pollutant with the highest concentration. It was observed that the removal efficiencies of PFASs (per-/polyfluoroalkyl substances) in wastewater treatment plants were lower than those of pesticides; further, those of pesticides were lower than those of PhACs. Based on the spatial agglomeration estimated by the spatial autocorrelation model, the probable sources of 28 contaminants were identified. This model provided a new perspective that would help to clarify the location of sources with high accuracy. The point sources of 6 PFASs and 14 PhACs were successfully found; in contrast, the main source of pesticides was identified as an agricultural nonpoint source. Finally, the potential risks of the ECs were also assessed in this study, including their aquatic ecological risks and human exposure risks. It was concluded that pesticides generally had the highest ecological risk, followed by PFASs and PhACs. To evaluate the population risk of pesticides, the wastewater-based epidemiological model was extended to back-calculate the per capita pesticide consumption, which was 0.22 g d-1 (103capita)-1.

This work primarily emphases on evaluating the prevalence of organic micropollutants (OMPs) in the perennial Yamuna River (YR) that flow through the national capital of India, Delhi. Sixteen sampling campaigns (non-monsoon, n = 9; monsoon n = 7) were organized to understand the seasonal variations with special emphasis on monsoon. We have found fifty-five OMPs in the monsoon; while forty-seven were detected in non-monsoon. Fifty-seven screened and quantified OMPs in the most polluted stretch of River Yamuna included the pharmaceutically active compounds, pesticides, endocrine-disrupting chemicals, phthalates, personal care products, fatty acids, food additives, hormones, and trace organics present in hospital wastes. During monsoon months, compounds for which concentrations exceeded 50 μg/L were: adenine (64.6 μg/L), diethyl phthalate (62.9 μg/L), and octamethyltrisiloxane (56.9 μg/L); and the same for non-monsoon months was only for 1-dodecanethiol (52.3 μg/L). The average concentration of OMPs in non-monsoon months indicate PhACs>PCPs>Pesticides>Fatty acids>Hospital waste>Hormones>Pesticides>EDCs. In monsoon months due to surface runoff and high volume of untreated wastewater discharges few more OMPs concentrations were detected which mainly includes PhACs (clofibric acid, diclofenac sodium, gemfibrozil, ketoprofen), pesticides (aldrin, metribuzin, atrazine, simazine). Due to dilution effect in the monsoon months, average concentrations of 3-acetamido-5-bromobenzoic acid (PhACs) was reduced from 45.22 μg/L to 14.07 μg/L, whereas some EDCs such as 2,4- Di-tert-amylphenol, 3,5- di-tert-butyl-4-hydroxybenzyl alcohol, Triphenylphosphine oxide, Benzophenone were found in much higher concentrations in the monsoon months. Octamethyltrisiloxane (PCPs) was detected 50 times higher in concentration in the monsoon months. Interestingly, the concentration of about 50 % of the OMPs was more in the monsoon samples than in non-monsoon samples which is contrary to the general understanding that monsoon-induced dilution lowers the concentrations of OMPs. In RY water higher magnitude of diclofenac sodium, ibuprofen, ketoprofen, and clofibric acid was found than Europe and North America rivers. Hormones such as estriol and estrone in RY water are found 70 to 100 times higher than the maximum reported concentrations in the US streams. Finally, various OMPs responded differently to the monsoon season as evident from multivariate analyses.

The availability of pharmaceutically active compounds (PhACs) in surface waters and suspended solids/sediments presents an ecological hazard of chronic exposure to non-target organisms. Thus, water and sediment samples were collected from the Korle Lagoon in the west of Accra-Ghana city center to evaluate 35 medicinal drugs belonging to the main therapeutic classes and their toxicity to non-target organisms (i.e., fish, daphnid, and algae). High-performance liquid chromatography coupled to mass spectrometry (HPLC-MS/MS) was employed to analyze the levels of PhACs in the samples. PhACs levels in water samples were higher compared to PhACs levels in sediment samples. Acetaminophen, ibuprofen, tramadol, and Diclofenac were the PhACs that showed a higher frequency of detections and higher average concentrations. Diazepam, mefenamic acid, indomethacin, gemfibrozil, and glibenclamide exhibited a higher frequency of detections, but their average concentrations in both sample types were lower. The calculated risk index values for acetaminophen and ibuprofen suggested low ecological risks to fish, while tramadol showed medium to high ecological risks to daphnid. In contrast, acetaminophen and fenofibrate showed low ecological risks to daphnid. Additionally, the risk index values for fenofibrate suggested medium to high ecological risks to algae, while tramadol exhibited low ecological risks to algae. The other PhACs showed negligible ecological risks to non-target organisms. The calculated toxic unit values for each sampled site suggested a medium adverse ecological risk to non-target organisms. Based on the results obtained, the availability of PhACs in the studied area will have adverse effects on studied non-target organisms. The negative impacts of PhACs on non-target organisms may cause an imbalance in the food chain process, leading to a decrease in fish production and a reduction in fish quality. The result of this study is evidence of public health threat because the accumulation of PhACs in fish species may also cause some kinds of hormonal, chemical, and molecular changes within the various systems of the fishes to be toxic or unpleasant for humans\' consumption.